Vanberra Signal

NQuiX

Curated by Signal

Provider of chemoinformatics services for drug discovery

Overview

NQuiX is a company offering in silico drug discovery services such as chemical informatics, computational chemistry, and molecular modeling company and works along with preclinical drug discovery teams, CROs and specialist software companies. Their capabilities include virtual screening, protein-protein interaction inhibitor design, and chemogenomics/chemical biology. The company also has proprietary offerings which complement the best and commercially available ones. They also offer screening libraries which have been designed in collaboration with Enamine and has over 8000+ compounds. They offer their services right from hit discovery to lead generation and optimization.

Key facts

Founded
2011

Business model

More on Vanberra Signal

Members only

Competitors & similar companies

More Health Technology companies
  • Provider of emergency ambulance service booking platform

    Health TechnologyWinchester, United Kingdom
  • Provider of hemp-based wellness products to maintain health

    Health TechnologyPeterborough, United Kingdom
  • AI-driven tool to assist individuals in assessing their mental health

    Health TechnologyLondon, United Kingdom

About NQuiX

What does NQuiX do?

NQuiX is a company offering in silico drug discovery services such as chemical informatics, computational chemistry, and molecular modeling company and works along with preclinical drug discovery teams, CROs and specialist software companies.

Where is NQuiX headquartered?

NQuiX is headquartered in Bishop s Stortford, United Kingdom.

When was NQuiX founded?

NQuiX was founded in 2011.

Which sector is NQuiX in?

NQuiX operates in Health Technology.

Who are NQuiX's competitors?

Companies similar to NQuiX include Wonston CPADS, Herb40, and Hana.